Kuan Arthur
Known title: Chief Executive OfficerCIK: 0002007101
Associated companies
Transaction History
| CGON | ▲ Buy | Option Exercise | 64,612 | $111K | 3/12/2026 | View on chart |
| CGON | ▼ Sell | Tax Withholding | 1,847 | $111K | 3/12/2026 | View on chart |
| CGON | ▲ Buy | Option Exercise | 102,871 | $177K | 3/4/2026 | View on chart |
| CGON | ▼ Sell | Tax Withholding | 2,871 | $177K | 3/4/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
CG Oncology appoints Isabel Kalefonos as Chief Commercial Officer
CG Oncology announced the appointment of Isabel Kalefonos as its new chief commercial officer. The hire adds experienced biopharmaceutical leadership as the company prepares for a possible bladder cancer product launch. The addition may strengthen the commercial strategy ahead of upcoming market activities.
CG Oncology appoints Isabel Kalefonos as Chief Commercial Officer. CG Oncology announced the appointment of Isabel Kalefonos as its new chief commercial officer. The hire adds experienced biopharmaceutical leadership as the company prepares for a possible bladder cancer product launch. The addition may strengthen the commercial strategy ahead of upcoming market activities.